![](/img/cover-not-exists.png)
Control of relapse due to minimal residual disease (MRD) by cell-mediated cytokine-activated immunotherapy in conjunction with bone marrow transplantation
Shimon Slavin, Aliza Ackerstein, Urania Vourka-Karussis, Arnon Nagler, Reuven Or, Elizabeth Naparstek, Lola WeissVolume:
4
Year:
1991
Language:
english
Pages:
11
DOI:
10.1016/s0950-3536(09)90009-9
File:
PDF, 778 KB
english, 1991